CHARLES A. BLIXT

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GYRE THERAPEUTICS, INC.

Filing Date Source Excerpt
2012-04-20 Mr. Blixt brings to the Board extensive legal, policy, corporate development and business experience. In particular, his experience gained over many years as general counsel of a Fortune 100 consumer products company serves as a balance to the emerging growth and life science backgrounds of the other members of the Board and provides the Board with a unique and valuable perspective. In addition, Mr. Blixt’s legal background helps the Board promote strong corporate governance practices.
2013-04-17 Mr. Blixt brings to the Board extensive legal, policy, corporate development and business experience. In particular, his experience gained over many years as general counsel of a Fortune 100 consumer products company serves to diversify the emerging growth and life science backgrounds of the other members of the Board and provides the Board with a unique and valuable perspective. In addition, Mr. Blixt’s legal background helps the Board promote strong corporate governance practices.
2014-04-18 Charles A. Blixt has been a member of the Board since August 2000. From October 2007 to December 2010, Mr. Blixt was a senior adviser to Jones Day, a law firm... Mr. Blixt brings to the Board extensive legal, policy, corporate development and business experience.

Data sourced from SEC filings. Last updated: 2026-02-03